Omar Al Tabaa

Pontoise, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Giant Cell Arteritis/Polymyalgia Rheumatica and Atypical Pulmonary Carcinoid Tumor: A Paraneoplastic Syndrome?

Giant Cell Arteritis/Polymyalgia Rheumatica and Atypical Pulmonary Carcinoid Tumor: A Paraneoplastic Syndrome?

Journal: The American journal of case reports

Published: February 05, 2026

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.

Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.

Journal: Clinical rheumatology

Published: January 26, 2026

Obinutuzumab after rituximab-induced allergy in difficult to treat rheumatoid arthritis: a case report of safe and effective management.

Obinutuzumab after rituximab-induced allergy in difficult to treat rheumatoid arthritis: a case report of safe and effective management.

Journal: Rheumatology (Oxford, England)

Published: June 18, 2025

Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study.

Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study.

Journal: Rheumatology (Oxford, England)

Published: January 24, 2025

Granulocytes and monocytes apheresis for polyarthritis in a multimorbid patient.

Granulocytes and monocytes apheresis for polyarthritis in a multimorbid patient.

Journal: Joint bone spine

Published: September 09, 2024

Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis.

Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis.

Journal: Seminars in arthritis and rheumatism

Published: May 01, 2024

Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica.

Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica.

Journal: Joint bone spine

Published: February 17, 2024

Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?

Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?

Journal: Rheumatology (Oxford, England)

Published: June 19, 2023

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease.

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease.

Journal: RMD open

Published: October 31, 2022

Whipple's disease: a rare cause of sacroiliitis.

Whipple's disease: a rare cause of sacroiliitis.

Journal: RMD open

Published: October 21, 2022

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.

Journal: RMD open

Published: May 04, 2022

Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection.

Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection.

Journal: Rheumatology (Oxford, England)

Published: February 05, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026